Nanjing Leads Biolabs Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SEHK:9887 Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
29 Jul 25	SellHK$389,000	Honggang Zuo	Individual	5,000	HK$77.80
28 Jul 25	SellHK$1,468,000	Honggang Zuo	Individual	20,000	HK$73.40
25 Jul 25	BuyHK$340,500	Honggang Zuo	Individual	5,000	HK$68.10

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 9887?
Owner Type	Number of Shares	Ownership Percentage
Public Companies	2,443,022	1.23%
VC/PE Firms	13,570,096	6.82%
Private Companies	24,113,716	12.1%
Individual Insiders	30,461,085	15.3%
General Public	38,828,742	19.5%
Institutions	89,475,139	45%

Dilution of Shares: 9887 only recently listed within the past 12 months

Top Shareholders

Top 25 shareholders own 66.35% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.82%	Loyal Valley Capital	13,570,096	HK$720.6m	0%	11.29%
6.46%	Nanjing Lizhi Management & Consulting Center (Limited Partnership)	12,845,442	HK$682.1m	0%	no data
4.79%	Hankang Capital	9,535,910	HK$506.4m	0%	66.1%
3.96%	Xiaoqiang Kang	7,874,617	HK$418.1m	0%	no data
3.53%	Dongcheng Lu	7,023,307	HK$372.9m	0%	no data
3.5%	Huaige Capital	6,960,695	HK$369.6m	0%	no data
3.21%	Shoupeng Lai	6,384,821	HK$339.0m	0%	no data
2.97%	Nanjing Ennovation Raylight Healthcare Investment Partnership (Limited Partnership)	5,901,290	HK$313.4m	0%	no data
2.85%	Beijing HosenCare Investment Management Co., Ltd.	5,662,889	HK$300.7m	0%	no data
2.42%	Ningbo Zhirong Beita Investment Management Co., Ltd.	4,817,264	HK$255.8m	0%	no data
2.34%	Lapam Capital	4,662,821	HK$247.6m	0%	13.14%
2.18%	Hangzhou Huafang Chuangliang Investment Management Co., Ltd.	4,336,722	HK$230.3m	0%	100.0%
2.17%	Nanjing Jieyuan Investment Management Partnership Enterprise (L.P.)	4,324,503	HK$229.6m	0%	no data
1.98%	Shanghai Zhuangzhong Venture Investment Co., Ltd.	3,941,250	HK$209.3m	0%	no data
1.92%	Renhai Chen	3,814,525	HK$202.6m	0%	no data
1.84%	Shanghai Guohong Zhizhen Venture Capital Co., Ltd.	3,664,534	HK$194.6m	0%	100.0%
1.74%	Jacky Zhuang	3,463,815	HK$183.9m	0%	no data
1.67%	Shenzhen Capital Group Co., Ltd.	3,330,592	HK$176.9m	0%	0.98%
1.67%	Xiamen Dyee Evergreen Venture Investment Partnership Enterprise (Limited Partnership)	3,330,584	HK$176.9m	0%	no data
1.64%	New Vision Ventures	3,261,914	HK$173.2m	0%	no data
1.54%	Ennovation Ventures	3,053,782	HK$162.2m	0%	no data
1.53%	Beijing Hankang Jianxin Venture Investment Co., Ltd.	3,036,869	HK$161.3m	0%	no data
1.23%	KPC Pharmaceuticals,Inc.	2,443,022	HK$129.7m	0%	no data
1.23%	Beijing Jiuyo Capital Management Co., Ltd.	2,443,022	HK$129.7m	0%	no data
1.14%	CCBI Venture Investment	2,275,954	HK$120.9m	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/11/20 18:45
End of Day Share Price	2025/11/20 00:00
Earnings	2025/06/30
Annual Earnings	2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Nanjing Leads Biolabs Co., Ltd. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Yonglin Yan	CLSA
Yu Wu	CMB International Securities Limited
Po Han Lin	Morgan Stanley